Skip to main content
HR 4820 99th Congress House Health Consumer education Consumer protection Drug industry Drug safety and regulation Drugs Drugs and narcotics Foreign Trade and Investments Government paperwork Government records, documents, and information Import restrictions Imports Licenses

Prescription Drug Marketing Act of 1986

Introduced: May 14, 1986 See on congress.gov
This bill died when the 99th Congress ended
It never became law before the 99th Congress (1985–1986) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 7 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 7, 1986
Ordered to be Reported (Amended).
Oct 7, 1986
Committee Consideration and Mark-up Session Held.
Sep 23, 1986
Forwarded by Subcommittee to Full Committee (Amended).
Sep 23, 1986
Subcommittee Consideration and Mark-up Session Held.
May 22, 1986
Referred to Subcommittee on Health and the Environment.
May 14, 1986
Referred to House Committee on Energy and Commerce.
May 14, 1986
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Prescription Drug Marketing Act of 1986 - Amends the Federal Food, Drug, and Cosmetic Act to permit only the U.S. manufacturer of a drug to reimport such drug into the United States.

Prohibits the sale of prescription drug samples. Permits the distribution of samples only to practitioners licensed to prescribe such drugs. Requires such practitioners to return a receipt for such drug samples to the manufacturers to be kept and made available to Federal and State officials.

Requires drug wholesalers to provide drug purchasers with a statement identifying the manufacturer and each sale of the drug. Directs the Secretary of Health and Human Services to issue licensing standards for drug wholesalers.

What's happening now October 7, 1986

Ordered to be Reported (Amended).

 Related & companion bills 1
 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4820: Prescription Drug Marketing Act of 1986. 99th Congress. Open America. https://openamerica.io/bill/99-HR-4820/
MLA
"H.R. 4820: Prescription Drug Marketing Act of 1986." 99th Congress, 2026, Open America, https://openamerica.io/bill/99-HR-4820/.
Bluebook (legal)
H.R. 4820, 99th Cong. (2026), https://openamerica.io/bill/99-HR-4820/.
Markdown link
[H.R. 4820: Prescription Drug Marketing Act of 1986](https://openamerica.io/bill/99-HR-4820/)
Report a problem